Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression

Upregulation of lncRNA MEG3 enhances hepatic insulin resistance via increasing foxO1expression, suggesting that MEG3 may be a potential target and therapeutic strategy for diabetes.